Ophthalmology, Retina Specialist · Chula Vista, CA
NPI
1164637153
Since 2007
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
835 3rd Ave, Suite A
Chula Vista, CA, 91911
Phone (619) 425-7755
Groups this clinician bills Medicare through
Medicare paid, 2024
$608K
8,622 services
Medicare patients, 2024
1,848
Average age 74
Drug cost, 2024
$2.0M
10,093 prescriptions
Company payments, 2025
$714
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tayson Delengocky was code 92014 (ophthalmological e&m), 2,075 times for 1,420 patients. In total Tayson Delengocky billed 8,622 services in 42 codes, and Medicare paid $608K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 2,075 | 1,420 | $89.07 | $185K |
| 92250 Angiography | Office | 1,560 | 1,353 | $27.02 | $42K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,005 | 667 | $31.19 | $31K |
| 92235 Angiography | Office | 633 | 607 | $128.29 | $81K |
| 92012 Ophthalmological E&M | Office | 574 | 476 | $66.38 | $38K |
| 92133 Computerized Ophthalmic Imaging | Office | 564 | 498 | $26.62 | $15K |
| 67028 Intravitreal Injection | Office | 444 | 110 | $87.11 | $39K |
| J7999 Compounded drug, not otherwise classified | Office | 417 | 107 | $71.97 | $30K |
| 92083 Vision, Hearing, and Speech Services | Office | 344 | 331 | $47.40 | $16K |
| 99214 Office E&M - Established | Office | 181 | 168 | $92.02 | $17K |
| 92004 Ophthalmological E&M | Office | 148 | 148 | $90.97 | $13K |
| 68761 Eye | Office | 124 | 122 | $166.88 | $21K |
| 67228 Eye | Office | 83 | 55 | $260.75 | $22K |
| 99213 Office E&M - Established | Office | 83 | 82 | $61.07 | $5,069 |
| 99204 Office E&M - New | Office | 72 | 72 | $101.55 | $7,312 |
By year: 2022 $612K for 9,138 services; 2023 $587K for 8,476 services; 2024 $608K for 8,622 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tayson Delengocky prescribed most often to Medicare patients was Latanoprost, with 1,972 prescriptions and refills. In total Tayson Delengocky wrote 10,093 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,972 | 3,446 | 480 | $24K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 976 | 1,493 | 214 | $19K |
| Timolol Maleate Generic | 917 | 1,561 | 227 | $9,425 |
| Cyclosporine Generic | 815 | 1,604 | 267 | $463K |
| Ketorolac Tromethamine Generic | 793 | 1,016 | 264 | $15K |
| Cromolyn Sodium Generic | 500 | 776 | 217 | $5,691 |
| Brimonidine Tartrate Generic | 403 | 648 | 95 | $22K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 390 | 424 | 94 | $135K |
| Cequa Cyclosporine | 331 | 483 | 103 | $280K |
| Xiidra Lifitegrast | 325 | 492 | 116 | $322K |
| Restasis Cyclosporine | 301 | 431 | 105 | $265K |
| Lumigan Bimatoprost | 301 | 426 | 74 | $111K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 263 | 273 | 187 | $2,904 |
| Tobramycin Generic | 238 | 253 | 144 | $1,222 |
| Prednisolone Acetate Generic | 174 | 227 | 127 | $5,329 |
Brand drugs: 4,139 claims; generic drugs: 5,954 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tayson Delengocky $714 ($714 in general payments such as food, travel and fees) from 7 companies. The largest payer was Bausch & Lomb Americas Inc. with $221.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.